Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysisThi Lien-Anh Nguyên, John Hiscott, Hesham Abdelbary et al.|Proceedings of the National Academy of Sciences|2008Cited by 182
Immunotherapy for sarcomas: new frontiers and unveiled opportunitiesHarsimrat Kaur Birdi, Michele Ardolino, Carolyn Nessim et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 70